WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 3 fonti

The promises and pitfalls of GLP-1 drugs

Approved 20 years ago as a diabetes treatment, GLP-1 drugs have been found to help patients reduce weight, changing the lives of more than 30 million people in the U.S. But there also have been troubling side effects reported.

Raccontata dacbsnews.comafr.comstatnews.com

Confronto fonti

3 prospettive sulla stessa storia
AI · summaries
cbsnews.comStai leggendo1 g fa

The promises and pitfalls of GLP-1 drugs

Approved 20 years ago as a diabetes treatment, GLP-1 drugs have been found to help patients reduce weight, changing the lives of more than 30 million people in the U.S. But there also have been troubling side effects…

originale
afr.com7 h fa

Here’s how GLP-1 drugs could save your life, as well as make you slim

GLP-1s may be able to alter the body’s inflammatory and metabolic environment making cancer therapies more effective. Clinical trials will be the next step.

Leggi questa versione → originale

Timeline cronologica

  1. domenica 7 giugno 2026·cbsnews.com

    The promises and pitfalls of GLP-1 drugs

    Approved 20 years ago as a diabetes treatment, GLP-1 drugs have been found to help patients reduce weight, changing the lives of more than 30 million people in the U.S. But there…

  2. lunedì 8 giugno 2026·afr.com

    Here’s how GLP-1 drugs could save your life, as well as make you slim

    GLP-1s may be able to alter the body’s inflammatory and metabolic environment making cancer therapies more effective. Clinical trials will be the next step.

statnews.com6 h fa

AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trials

AstraZeneca’s GLP-1 pill showed promise in mid-stage obesity and diabetes studies, but it may still be too early to determine how it stacks up against other oral treatments.

Leggi questa versione → originale
  • lunedì 8 giugno 2026·statnews.com

    AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trials

    AstraZeneca’s GLP-1 pill showed promise in mid-stage obesity and diabetes studies, but it may still be too early to determine how it stacks up against other oral treatments.